More and more pharma and biopharma companies discover the business value of resource planning and scheduling.
There is a strong need to optimize the utilization and planning adherence of analysts, scientists and the equipment they use in the quality control labs, R&D labs or pilot plants for process development.
Strategy consultants and industry watchers see a clear position for resource planning and scheduling in their Industry 4.0 vision.
- BCG positions resource planning and scheduling in Industry 4.0 showcases in their Innovation Centers for Operations (ICO).
- Also, McKinsey values the predictive aspects of a lab planning platform in their article about the lab of the future.
- Earlier we wrote about how Gartner picked up the signal about the increasing resource planning needs.
Also for Binocs, we surf the wave. In the last 6 months, we received more than five RFQs from big pharma players for a global solution for resource planning and scheduling solution in QC and R&D labs.
However, the resource planning theme is not a paved path like LIMS and ERP are. In our interactions with companies, we see that the selection teams still struggle with defining a well-tuned list of user requirements.